Pulse Explorar nav.journalClub Debates Tendencias Investigadores

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Inicio Explorar nav.journalClub Tendencias

⌘+K

February 26, 2024Open Access

Ver artículo completo

Resmetirom: Finally, the Light at the End of the NASH Tunnel?

ALAmedeo LonardoAzienda Unita' Sanitaria Locale Di Modena

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

Nonalcoholic steatohepatitis (NASH) is a double composite word that was first coined in 1980 by Ludwig and Colleagues ...

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Cite This Study

Amedeo Lonardo (Mon,) studied this question.

synapsesocial.com/papers/68e778cdb6db6435876ed1e1 https://doi.org/https://doi.org/10.3390/livers4010010

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Resmetirom: Finally, the Light at the End of the NASH Tunnel? | Synapse

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Pathogenesis of hypothyroidism-induced NAFLD is driven by intra- and extrahepatic mechanisms2017 · 80 citations
2Should combination therapy be the paradigm for future nonalcoholic steatohepatitis clinical trials?2011 · 10 citations
3Why Do So Many Nonalcoholic Steatohepatitis Trials Fail?2020 · 85 citations
4Resmetirom for nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled phase 3 trial2023 · 395 citations
5Thyroid function, adipokines and mitokines in metabolic dysfunction‐associated steatohepatitis: A multi‐centre biopsy‐based observational study2024 · 15 citations